Trupanion, Inc. (NASDAQ:TRUP - Get Free Report) SVP Emily Dreyer sold 14,025 shares of the business's stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $32.41, for a total transaction of $454,550.25. Following the completion of the transaction, the senior vice president now directly owns 27,645 shares of the company's stock, valued at approximately $895,974.45. This represents a 33.66 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.
Trupanion Trading Down 1.5 %
NASDAQ TRUP traded down $0.51 during trading hours on Thursday, hitting $33.58. The company's stock had a trading volume of 650,452 shares, compared to its average volume of 643,952. Trupanion, Inc. has a twelve month low of $19.69 and a twelve month high of $57.90. The firm has a market capitalization of $1.43 billion, a P/E ratio of -146.00, a PEG ratio of 6.02 and a beta of 1.70. The company has a quick ratio of 1.66, a current ratio of 1.71 and a debt-to-equity ratio of 0.39. The stock has a fifty day moving average of $42.92 and a 200 day moving average of $47.14.
Trupanion (NASDAQ:TRUP - Get Free Report) last posted its quarterly earnings results on Wednesday, February 19th. The financial services provider reported $0.04 earnings per share for the quarter, missing analysts' consensus estimates of $0.06 by ($0.02). Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.08%. The company had revenue of $337.31 million during the quarter, compared to analyst estimates of $335.41 million. Equities research analysts forecast that Trupanion, Inc. will post 0.13 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Trupanion
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Sigma Planning Corp acquired a new stake in shares of Trupanion in the 3rd quarter valued at approximately $336,000. Entropy Technologies LP bought a new stake in Trupanion in the third quarter valued at approximately $202,000. GSA Capital Partners LLP raised its holdings in Trupanion by 51.3% in the third quarter. GSA Capital Partners LLP now owns 10,487 shares of the financial services provider's stock worth $440,000 after purchasing an additional 3,554 shares during the period. Victory Capital Management Inc. bought a new position in shares of Trupanion during the third quarter worth $261,000. Finally, Check Capital Management Inc. CA grew its holdings in shares of Trupanion by 2.7% in the 3rd quarter. Check Capital Management Inc. CA now owns 41,460 shares of the financial services provider's stock valued at $1,740,000 after buying an additional 1,100 shares during the period.
Analyst Ratings Changes
Several research analysts recently weighed in on the stock. Stifel Nicolaus dropped their price objective on shares of Trupanion from $44.00 to $41.00 and set a "hold" rating for the company in a research report on Thursday, February 20th. Piper Sandler dropped their target price on Trupanion from $57.00 to $52.00 and set an "overweight" rating for the company in a research report on Thursday, February 20th. Two research analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, Trupanion has an average rating of "Moderate Buy" and a consensus price target of $46.60.
Check Out Our Latest Analysis on Trupanion
Trupanion Company Profile
(
Get Free Report)
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
See Also

Before you consider Trupanion, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Trupanion wasn't on the list.
While Trupanion currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.